{"id":5044,"date":"2023-02-13T00:00:03","date_gmt":"2023-02-13T00:00:03","guid":{"rendered":"https:\/\/eu.bd.com\/iv-news\/?p=5044"},"modified":"2023-02-09T09:52:24","modified_gmt":"2023-02-09T09:52:24","slug":"cvam-care-bundles-how-we-can-measure-their-economic-benefit","status":"publish","type":"post","link":"https:\/\/eu.bd.com\/iv-news\/news-innovation\/cvam-care-bundles-how-we-can-measure-their-economic-benefit\/","title":{"rendered":"CVAM care bundles: how we can measure their economic benefit"},"content":{"rendered":"

Central vascular access devices (CVADs) allow for blood collection, nutritional support and medication administration when these cannot be provided safely through peripheral vascular access devices (PVADs)1<\/sup>.<\/p>\n

However, intravenous (IV) therapy with CVADs are associated with frequent preventable complications, morbidity and healthcare costs1,2<\/sup>. Over 15% of patients who receive CVADs experience complications1<\/sup>.<\/p>\n

More on this topic: <\/strong>What is the real cost of vascular access-related complications?<\/a><\/p>\n

CVAM care bundles: assessment with a health economics model<\/strong><\/h4>\n

A health economic model has been developed to estimate the number and cost of complications, the cost of consumables, and nurse time spent managing catheters for a cohort of patients, where the risk of complications could be varied by the length of catheter placement and the expected impact of the vascular access management (VAM) strategies selected.<\/p>\n

This model compares two strategies including catheter selection and insertion and care and maintenance practices: one considered as a CVAM baseline\/current practice and the other as a best practice BD CVAM care bundle.<\/p>\n

The BD CVAM<\/a> care bundle is an integrated approach for vascular access device selection, placement, and care designed to help reduce vascular access related complications which may lead to improved patient care.<\/p>\n

The baseline practice utilised in the model includes: skin preparation with 5% povidone iodine and 69% ethanol, subcutaneous engineered stabilisation devices (SESDs), no needleless connectors, no disinfecting caps and intermittent flushing of the line.<\/p>\n

The BD CVAM care bundle includes: skin preparation with single-use applicators containing 2% chlorhexidine gluconate in 70% isopropyl alcohol (CHG-IPA), peripherally inserted central catheter (PICC) stablisation devices, positive-displacement needleless connectors, disinfecting caps and single-use pre-filled saline syringes.<\/p>\n

The use of disinfecting caps and pre-filled saline syringes has been found to reduce the time needed for catheter maintenance3,4<\/sup>.<\/p>\n

Zoom in on health economics<\/strong><\/h4>\n

This health economics model helps predict the budget impact when moving from baseline practice to the BD CVAM care bundle:<\/strong><\/p>\n